|1.||Pagel, Paul S: 16 articles (10/2009 - 01/2002)|
|2.||Kehl, Franz: 15 articles (06/2013 - 01/2002)|
|3.||Warltier, David C: 15 articles (10/2009 - 01/2002)|
|4.||Kersten, Judy R: 13 articles (09/2007 - 01/2002)|
|5.||Chio, Chung-Ching: 12 articles (02/2016 - 09/2007)|
|6.||Krolikowski, John G: 12 articles (10/2009 - 01/2002)|
|7.||Kuo, Jinn-Rung: 9 articles (02/2016 - 09/2007)|
|8.||Wang, Che-Chuan: 8 articles (02/2016 - 01/2010)|
|9.||Redel, Andreas: 8 articles (06/2013 - 09/2006)|
|10.||Saeed, Maythem: 7 articles (08/2015 - 01/2004)|
02/01/2009 - "Reperfused TgCOX-2 hearts after 40 min of ischemia improved functional recovery (32.9+/-6.2% vs. 9.45+/-4.4%, P=0.004) and reduced cell death assessed by LDH release (43% of reduction, P<0.001) and triphenyltetrazolium staining (41% of reduction, P=0.002). "
08/01/2011 - "The aim of the present study was to investigate if T(1)AM is able to reduce irreversible tissue injury in isolated rat hearts subjected to ischemia and reperfusion, as evaluated by triphenyltetrazolium chloride staining. "
12/01/2005 - "In ischemic tissue identified by 2,3,5-triphenyltetrazolium chloride (TTC) staining, the T(2) (dagger) increased by approximately 31% after 1 hour of ischemia and remained elevated until study completion at 4 h of ischemia. "
12/01/2014 - "Ischemic injury was induced by 30 minutes of global ischemia followed by 120 minutes of Langendorff reperfusion and evaluated on the basis of triphenyltetrazolium chloride staining. "
01/01/2014 - "The ischemia area was detected via 2,3,5-triphenyltetrazolium chloride staining. "
04/01/1999 - "To date, most studies of the second window of protection against infarction (SWOP) have evaluated infarct size by staining with triphenyltetrazolium chloride (TTC) soon after reperfusion. "
07/01/2007 - "The infarction volume determined with the 3D IR-FLASH in the animal study (2.4 +/- 1.5 cm(3)) showed a good correlation with the histomorphometrically determined volume using triphenyltetrazolium chloride (2.3 +/- 1.2 cm(3), r = 0.98, P < .001) and the two-dimensional IR-FLASH sequence (2.3 +/- 1.4 cm(3), r = 0.99, P < .001). "
05/01/2000 - "In the infarction study, the left anterior descending coronary artery was occluded for 35 min and infarct size was assessed by triphenyltetrazolium chloride staining. "
02/01/2016 - "Triphenyltetrazolium chloride (TTC) staining was also used to evaluate infarction volume. "
01/01/2015 - "Triphenyltetrazolium chloride (TTC) staining was used to monitor changes of infarction volume corresponding to different impact strengths. "
12/01/2001 - "Contrast injection followed by subsequent 23Na MRI in canine myocardial infarction led to a clear delineation of the location of the injured tissue, as identified by postmortem triphenyltetrazolium chloride staining, and to an improvement in the contrast-to-noise ratio between the blood in the ventricular chamber and the infarcted tissue that was as high as 3.3-fold in the postcontrast images in comparison to the precontrast images."
08/01/2015 - "Triphenyltetrazolium-chloride (TTC) and Masson-trichrome were used as gold standard references for macro and microscopic quantification of myocardial infarction (MI). "
11/01/1989 - "The dogs were sacrificed at the end of the study and the area of myocardial infarction was confirmed by triphenyltetrazolium chloride staining. "
11/10/2015 - "(131)I-SA was evaluated in rat model of 24-hour old reperfused myocardial infarction using single-photon emission computed tomography/computed tomography (SPECT/CT), biodistribution, triphenyltetrazolium chloride (TTC) histochemical staining, serial sectional autoradiography and microscopy. "
01/01/2015 - "Myocardial infarct size was examined with triphenyltetrazolium chloride staining. "
03/01/1990 - "Left ventricular function measured as percent control of developed pressure revealed significantly greater (p less than 0.05) recovery in groups 2 and 3. Triphenyltetrazolium chloride staining showed 35% +/- 9% (mean +/- standard error) of heart mass necrosis in group 1 versus 0% and 0.5% +/- 0.4% in groups 2 and 3, respectively (p less than 0.001). "
09/01/1986 - "Histochemical studies: inability of triphenyltetrazolium chloride nonstaining to define tissue necrosis."
01/01/2013 - "Necrosis is quantified after staining the heart with triphenyltetrazolium chloride."
01/01/2012 - "Necrosis was measured by 2,3,5-triphenyltetrazolium chloride (TTC) staining and expressed as percent of each myocardial segment. "
01/01/2010 - "Cardiac function was measured, and myocardial necrosis was evaluated by triphenyltetrazolium chloride staining at the end of the reperfusion. "
|5.||Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/01/2014 - "After 3 weeks, the experiments of middle cerebral artery occlusion, the modified neurological severity score (mNSS), an inclined plane test, and triphenyltetrazolium chloride were performed to evaluate the effectiveness of the proposed platform. "
05/01/2014 - "Infarct volumes were examined via either 2,3,5-triphenyltetrazolium chloride assay or magnetic resonance imaging 72 hours after middle cerebral artery occlusion. "
04/30/2014 - "A model of middle cerebral artery occlusion was induced for 2h followed by reperfusion and the infarct size was determined by 2,3,5-triphenyltetrazolium chloride (TTC) staining 6h, 24h, 3 days, and 7 days after reperfusion. "
04/23/2012 - "Permanent middle cerebral artery occlusion (MCAo) was induced and the ischemic brain was observed by 2,3,5-triphenyltetrazolium chloride (TTC) staining. "
01/01/2012 - "Mice with left common carotid artery occlusion (CCAO) were additionally subjected to middle cerebral artery occlusion, and stroke volumes were assessed after triphenyltetrazolium chloride staining. "
|3.||Nerve Growth Factor (NGF)
|5.||Eosine Yellowish-(YS) (Eosin)
|6.||Caspase 3 (Caspase-3)
|7.||salicylhydroxamic acid (SHAM)
|8.||1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)
|9.||Technetium Tc 99m Sestamibi (Cardiolite)